Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07195175 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study of MAR002 in Healthy Men

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated January 12, 2026 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Enrollment target: 37 to 45
    • Primary and study completion dates: May 2026 to Jul 2026
    • Secondary endpoints: details revised at 6 of 6 entries
    • Study arms: 5 to 6
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Evaluate the safety and tolerability of subcutaneous (SC) administration of MAR002 in healthy men
Trial Details
NCT Number NCT07195175
Lead Sponsor Marea Therapeutics
Conditions
(from sponsor)		 Acromegaly
Related terms Acromegaly
Enrollment 45 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov